Sign in
COAG Stock Price, Chart, Stats & News
Hemab Therapeutics Holdings, Inc. Common Stock
Save
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) does not currently pay a dividend.
97.30M
Market cap
–
Current P/E
–
Forward P/E
COAG chart
1M
3M
1Y
5Y
Loading chart...
About
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody.
Similar securities
Based on sector and market capitalization
Report issue